Alerts will be sent to your verified email
Verify Email
CBPL
|
Chandra Bhagat Pharm
|
Unick Fix-A-Form
|
Lasa Supergenerics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.7 % | 9.15 % | -8.32 % |
|
5yr Avg Net Profit Margin
|
0.58 % | 4.16 % | -8.22 % |
|
Price to Book
|
0.0 | 1.14 | 0.5 |
|
P/E
|
47.94 | 14.93 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
56.06 Days | 21.15 Days | 11.27 Days |
|
5yr Average Interest Coverage Ratio
|
1.54 | 2.62 | -18.91 |
|
5yr Avg ROCE
|
10.71 % | 12.8 % | 1.03 % |
|
5yr Avg Operating Profit Margin
|
2.17 % | 14.14 % | 9.99 % |
|
5 yr average Debt to Equity
|
0.85 | 0.86 | 0.2 |
|
5yr CAGR Net Profit
|
37.62 % | -7.47 % | n/a |
|
5yr Average Return on Assets
|
0.95 % | 3.64 % | -5.59 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.2 % | 71.57 % | 53.65 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 20.66 % |
|
Change in Promoter Holding (3 Yrs)
|
0.78 % | 35.92 % | 9.87 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Chandra Bhagat Pharm
|
Unick Fix-A-Form
|
Lasa Supergenerics
|
|---|